Identification of Genomic Signatures for Colorectal Cancer Survival Using Exploratory Data Mining
Clinicopathological presentations are critical for establishing a postoperative treatment regimen in Colorectal Cancer (CRC), although the prognostic value is low in Stage 2 CRC. We implemented a novel exploratory algorithm based on artificial intelligence (explainable artificial intelligence, XAI)...
Main Authors: | Justin J. Hummel, Danlu Liu, Erin Tallon, John Snyder, Wesley Warren, Chi-Ren Shyu, Jonathan Mitchem, Rene Cortese |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/25/6/3220 |
Similar Items
-
Loss of SATB2 Occurs More Frequently Than CDX2 Loss in Colorectal Carcinoma and Identifies Particularly Aggressive Cancers in High-Risk Subgroups
by: Maxime Schmitt, et al.
Published: (2021-12-01) -
Single-cell transcriptional signature-based drug repurposing and in vitro evaluation in colorectal cancer
by: Roohallah Mahdi-Esferizi, et al.
Published: (2024-03-01) -
ARE CDX2, BETA-CATENIN AND WNT IMMUNOMARCHERS USEFUL FOR EVALUATING THE CHANCE OF DISEASE PROGRESSION OR EVOLUTION TO DEATH IN PATIENTS WITH COLORECTAL CANCER?
by: Fabiola Pabst BREMER, et al.
Published: (2020-12-01) -
Diagnostic and Prognostic Roles of CDX2 Immunohistochemical Expression in Colorectal Cancers
by: Hong Bae Choi, et al.
Published: (2022-03-01) -
CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathway
by: Janina Graule, et al.
Published: (2018-09-01)